ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $28,000 | +7.7% | 18,930 | +4.6% | 0.00% | – |
| Q4 2016 | $26,000 | +271.4% | 18,096 | +365.2% | 0.00% | – |
| Q3 2016 | $7,000 | +40.0% | 3,890 | +37.0% | 0.00% | – |
| Q2 2016 | $5,000 | +25.0% | 2,840 | +35.2% | 0.00% | – |
| Q1 2016 | $4,000 | -97.7% | 2,100 | -97.7% | 0.00% | – |
| Q4 2015 | $172,000 | +537.0% | 90,777 | +553.7% | 0.00% | – |
| Q3 2015 | $27,000 | -22.9% | 13,887 | +82.7% | 0.00% | – |
| Q2 2015 | $35,000 | -53.3% | 7,600 | -55.6% | 0.00% | – |
| Q1 2015 | $75,000 | +1.4% | 17,100 | -20.2% | 0.00% | – |
| Q4 2014 | $74,000 | +428.6% | 21,439 | +556.0% | 0.00% | – |
| Q3 2014 | $14,000 | -57.6% | 3,268 | -41.2% | 0.00% | – |
| Q2 2014 | $33,000 | -2.9% | 5,558 | +3.2% | 0.00% | – |
| Q1 2014 | $34,000 | -86.6% | 5,386 | -87.6% | 0.00% | – |
| Q4 2013 | $254,000 | -62.0% | 43,428 | -65.8% | 0.00% | – |
| Q3 2013 | $669,000 | +562.4% | 126,915 | +867.9% | 0.00% | – |
| Q2 2013 | $101,000 | – | 13,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
| DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
| SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
| Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
| FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
| GAM Holding AG | 523,164 | $997,000 | 0.02% |
| STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |